RxDoctor Payments Data

Belinda Johnson, MD

Family Medicine · Temple Terrace, FLNPI 1386891760

Payments from drug & device makers

$1,033in general payments, 2019–2025

Across 21 payments — averaging $49.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$234
  • AstraZeneca$225
  • Johnson & Johnson$174
  • Gilead$147
  • E.r. Squibb & Sons, L.L.C.$144
  • Mallinckrodt Hospital Products Inc.$56
  • plus $54 from 2 others

What the payments were for

  • Food & beverage$1,033100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK2$234
AstraZeneca2$225
Johnson & Johnson(2 entities)6$174
Gilead2$147
E.r. Squibb & Sons, L.L.C.4$144
Mallinckrodt Hospital Products Inc.2$56
AbbVie(2 entities)2$34
Pfizer1$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,033 in reported general payments places this provider in the 60th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$42,731
Medicare patients
231
Services billed
433

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban13$8,404
Gabapentin30$283
CefuroximeCefuroxime Axetil25$268
Ondansetron OdtOndansetron26$205
Pantoprazole Sodium28$154
Metoprolol Succinate13$125
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen24$122
Atorvastatin Calcium37$94
Losartan Potassium12$66
Cephalexin13$63
Amlodipine Besylate17$26
Prednisone19$22

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$20$8,40413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Temple Terrace

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →